I would have to think that once we do hear about iplex the share price is going to be much higher then what your predicting hhand. We both know big pharma wants iplex - Ipsen not making inclrelex alone makes iplex valuable to them. I'm sure if some big pharma offered $5 billion for insm ($200/share)...insm would turn it down
So, if Ipsen has a big pipeline for Increlex and no product, why haven't they just licensed Iplex? It doesn't make a lot of sense not to after all of the marketing expenses they've invested to build their base. It would also get Iplex back into the market for ALS, potentially MMD and a number of other indications. This doesn't make a lot of sense.
Lux, while I am a believer in INSM, the thought that INSM would turn down an offer that is 12 times the current share price is laughable. You are starting to sound like Fud. If you think such an offer is realistic, then you should be much more worried about the possibility of a buyout at much lower values right after NTM trial news...
A stock split is not out the question,would love to have my 62000 shares back instead of 6200,just saying. With all Lewis has planned for multiple apps I`ll also be a multi millionaire as the stock shoots right back up again after the split. I had 4k share of AAPL at 24.00 a share before both of the 2 for 1 stock splits-that 96k dollar investment would`ve yielded me over 11million,but I sold it after the first Ipod earnings at 22.00 for a loss of 8k.I need INSM to give me my second chance.